Thiophene derivatives as Sphingosine-1-phosphate-1 receptor...

Details Thiophene derivatives as Sphingosine-1-phosphate-1 receptor... Thiophene derivatives as Sphingosine-1-phosphate-1 receptor...

2006-03-20

2009-10-20

Saeed, Kamal A (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C549S060000, C514S365000

Reexamination Certificate

active

07605269

ABSTRACT:
The invention relates to novel thiophene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents.

REFERENCES:
patent: 6156787 (2000-12-01), Broughton et al.
patent: 2008/0176926 (2008-07-01), Bolli
patent: 2008/0194670 (2008-08-01), Bolli
patent: 2008/0257352 (2008-10-01), Penton
patent: 2008/0300294 (2008-12-01), Bolli
patent: 2008/0318955 (2008-12-01), Bolli
patent: 2009/0005421 (2009-01-01), Bolli
patent: WO-91/15583 (1991-10-01), None
patent: WO 99/46277 (1999-09-01), None
patent: WO 2003/062248 (2003-07-01), None
patent: WO-03/105771 (2003-12-01), None
patent: WO 2003/105771 (2003-12-01), None
patent: WO-2004/035538 (2004-04-01), None
patent: WO 2004/103279 (2004-12-01), None
patent: WO-2004/103279 (2004-12-01), None
patent: WO-2006/010379 (2006-02-01), None
patent: WO 2006/010544 (2006-02-01), None
Dubus et al. (Ann. Chim., 1975, vol. 10; p. 331-336.
T. Hla, et al., T.J. “An Abundant Transcript Induced in Differentiating Human Endothelial Cells Encodes a Polypeptide with Structural Similiarities to G-protein-coupled Receptors,” Biol Chem, 265 (1990), pp. 9308-9313.
Philip L. Gould, “Salt selection for basic drugs,” Int. J. Pharm., (1986), 33, pp. 201-217.
A.R. Gangloff, et al., “Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst,” Tetrahedron Lett, 42 (2001), pp. 1441-1443.
T. Suzuki, et al., “Synthesis of the Selective 5-Hydroxytryptamine 4 (5-HT)4) Receptor Agonist (+)-(s)-2-Chloro-5-methoxy-4-[2-piperidylmethyl)-1,2,4-oxadiaol-3-yl]aniline” Chem. Pharm. Bull., 47 (1999), pp. 120-122.
R.F. Poulain, et al., “Parallel synthesis of 1,2,4-oxadiazoles from carboxylic acides using an imroved, uronium-based, activation,” Tetrahedron Lett., 42 (2001), pp. 1495-1498.
R.M. Srivastava, et al., “Synthesis of 3-aryl-5-[thien-3-YL methtyl]-1.2.4-oxadiazoles,” Synthetic Commun. 29 (1999), pp. 1437-1450.
E.O. John, et al., “Reaction of (Difluoroamino) difluoroacetonitrile and (Difluoroamino) difluoroacetamidoxime,” Inorganic Chemisry, 27 (1988), pp. 3100-3104.
B. Kaboudin, et al., “One-pot synthesis of 1,2,4-oxadiazoles mediated by microwave irradiation under solvent-free condition,” Heterocycles 60 (2003), pp. 2287-2292.
A. Hamze, et al., J. Sythesis of a Various 3-Substitued 1,2,4-Oxadiazole-Contraining Chiral β3- and α-Amino Acids from Fmoc-Protected Aspartic Acid, J. Org. Chem. 68 (2003), pp. 7316-7321.
J. Cui, et al., “Design and Synthesis of Highly Constrained Factor Xa Inhibitors: Amidine-Substituted Bis(benzoyl)-[1,3]-diazepan-2-ones and Bis(benzylidene)-bis (gemdimethyl)cycloketones,” Bioorg. Med. Chem. 11 (2003), pp. 3379-3392.
T.W. Greene, et al., “Protective Groups in Organic Synthesis,” 3rd Edition, Wiley New York, 1991.
P.J. Kocienski, Protecting Group, Thieme Stuttgart, 1994.
C. D. Bedford et al., “Nonquaternary Cholinesterase Reactivators. 3. (3(5)-Substituted 1,2,4-Oxadiaxo1-5(3)-aldoximes and 1,2,4-Oxadiazole-5(3)-thiocarbohydroximates as Reactivators of Organophosphonate-Inhibited Eel and Human Acetylcholinesterase in Vitro,” J. Med. Chem. 29 (1986), pp. 2174-2183.
D. Dubus, et al., “Synthese De Diheterocycles En Serie Oxadiazole-1,2,4,” Annales de Chimie (Paris, France) 10 (1975), pp. 331-336.
B. Hedegaard, et al., “Thiophene Chemistry—XIX,” Tetrahedron 27 (1971), pp. 3853-3859.
S.A. Popov, et al., “Synthesis of New Chiral Heterocycles of the Pyrazole and 2-lsoxazoline Types from (+)-3-Carene,” Tetrahedron: Asymmetry vol, 5, No. 3 (1994), pp. 479-489.
S.A. Popov, et al., “Synthesis of 2-Alkyl and 2-Aryl Pyrimidines from β-Chlorovinyl Ketones of Cyclopentanone Type,” Synthetic Commmunications, 31(2), (2001), pp. 233-243.
W. Cocker, et al., “A Convenient Preparation of (−)-β-3,4-Epoxycarane,” Tetrahedron Letters No. 51, (1969), pp. 4451-4452.
S. Lochynski, et al., “Modification of Synthesis of Dihydrochrysanthemolactone from (+)-Car-3-ene,” Journ f. prakt. Chemie. Band 330, Heft 2, (1988), pp. 284-288.
M. Walkowicz, et al., “Uber Stereoisomere 6,6-Dimethyl-Bicyclo-[3.1.0]-Hexanole-3,” Roczniki Chemii Ann. Soc. Chim. Polonorum 41(1967) pp. 927-937.
H. Kuczynski, et al., “0 Krystalicznym (−)-Dwubromo-3,4-Karanie,” Roczniki Chemii Ann. Soc. Chim. Polonorum 38, (1964), pp. 1625-1633.
A.V. Pol, et al., “Oxidation of Δ3-Carene & α-Pinene with Thallium(III) Nitrate,” Indian J. Chem., vol. 19B, (1980) pp. 603-604.
B. Xu, et al., “Acyclic Analogues of Adenosine Bisphophates as P2Y Receptor Antagonists: Phosphate Substitution Leads to Multiple Pathways of Inhibition of Platelet Aggregation,” J. Med. Chem. 45 (2002), pp. 5694-5709.
V.M. Christi, et al., “Einige Valene von Benzanellierten fuenfgliedrigen Hetroarenen-Synthesen und NMR-Spektren,” Angewandte Chemie VCH Verlagsgesellschaft, Weinheim, DE, vol. 102, No. 6 (1990) pp. 704-706.
U.S. Appl. No. 11/993,563, filed Dec. 21, 2008, Actelion Pharmaceuticals Ltd.
U.S. Appl. No. 12/160,520, filed Jul. 10, 2008, Actelion Pharmaceuticals Ltd.

Affiliated with

Also associated with

Rating

Thiophene derivatives as Sphingosine-1-phosphate-1 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiophene derivatives as Sphingosine-1-phosphate-1 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiophene derivatives as Sphingosine-1-phosphate-1 receptor... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4057597